Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Sep-24 8:29 PM View:  | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Sep-24 | Sale (Planned) | 500 | $12.86 | $6,430.00 | (< 1%) 116.2K to 115.7K | |
| 03-Jul-24 6:52 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 28-Jun-24 | Grant | 160 | $24.32 | $3,899.99 | < 1% 116.04K to 116.2K | |
| 13-Jun-24 6:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 13-Jun-24 | Sale (Planned) | 1,000 | $28.38 | $28,380.00 | (< 1%) 117.04K to 116.04K | |
| 13-Jun-24 6:13 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 12-Jun-24 | Grant | 54,300 | -- | -- | 87% 62.74K to 117.04K | |
| 05-Jun-24 5:09 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 03-Jun-24 | Payment of Exercise | 2,754 | $30.89 | $85,071.10 | (4%) 65.49K to 62.74K | |
| 07-Feb-24 4:59 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Feb-24 | Grant | 33,700 | -- | -- | 106% 31.79K to 65.49K | |
| 07-Jun-23 9:22 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 07-Jun-23 | Sale | 1,047 | $37.87 | $39,644.70 | (5%) 22.59K to 21.54K | |
| 07-Jun-23 9:22 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-23 | Sale | 1,005 | $38.99 | $39,186.00 | (4%) 23.59K to 22.59K | |
| 07-Jun-23 9:22 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 05-Jun-23 | Sale (Planned) | 1,000 | $38.74 | $38,740.00 | (4%) 24.59K to 23.59K | |
| 02-Jun-23 6:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 31-May-23 | Option Exercise | 2,500 | $34.00 | $85,000.00 | 10% 24.59K to 27.09K | |
| 02-Jun-23 6:28 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 31-May-23 | Planned Option Sale | 2,500 | $39.08 | $97,700.00 | (9%) 27.09K to 24.59K | |
| 08-Jun-22 7:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 08-Jun-22 | Grant | 12,900 | -- | -- | 112% 11.49K to 24.39K | |
| 08-Jun-22 7:24 PM View: | Pacira Pharmaceuticals, Inc. (PCRX) | 06-Jun-22 | Market Sale | 1,106 | $61.37 | $67,879.60 | (9%) 12.6K to 11.49K | < 1% |